Let’s design solutions that’ll strengthen your company from the inside out.
Our research-led methodology will bring together relevant market fundamentals, your business‘ offerings, and all the people involved in them to reveal powerful insights and opportunities.
Opportunities that we’ll then design for, creating value for you by accounting for everybody.
Our research-led methodology will bring together relevant market fundamentals, your business‘ offerings, and all the people involved in them to reveal powerful insights and opportunities.
Opportunities that we’ll then design for, creating value for you by accounting for everybody.
inVentiv Health
Change Management / Global Corporate Brand Integration & Unification Strategy / Business Capabilities & Operations Architecture / Design Systems for Print, Digital, Video, and Environment / Corporate Visioning / Experience Design / Brand Identity & Interface Design / Design Leadership
For Chandler Chicco Agency, New York City, NY
︎ where we were inVentiv Health had formed by aqcuisition of various subsidiaries and international business segments all at varying stages of brand evolution.
︎where we wanted to be A unified inVentiv Health, positioned as a global leader in convergent clinical and commercial healthcare services.
︎ how we got there By first mapping company-wide business capabilities and products on offer across the B2B supply-chain, we were able to design an organizational system that would enable cross-collaboration between the inVentiv Health subsidiaries.
Change Management / Global Corporate Brand Integration & Unification Strategy / Business Capabilities & Operations Architecture / Design Systems for Print, Digital, Video, and Environment / Corporate Visioning / Experience Design / Brand Identity & Interface Design / Design Leadership
For Chandler Chicco Agency, New York City, NY
︎ where we were inVentiv Health had formed by aqcuisition of various subsidiaries and international business segments all at varying stages of brand evolution.
︎where we wanted to be A unified inVentiv Health, positioned as a global leader in convergent clinical and commercial healthcare services.
︎ how we got there By first mapping company-wide business capabilities and products on offer across the B2B supply-chain, we were able to design an organizational system that would enable cross-collaboration between the inVentiv Health subsidiaries.
Then, to transition inVentiv Health into a single convergent solutions provider, we established a horizontal brand architecture and created core tools and communication assets for integrated cross-application. By building structure and flexibility into the corporate brand identity system, we facilitated multi-disciplinary teams and implementing new ways to create organic, cross business-unit relationships.
With new collaborations, opportunities to develop convergent solutions for healthcare clients became the norm and the company began to operate with singularity in its purpose. After three years of space-making, we had finally established an organized and integrated operations which brought together a Contract Research Organization (CRO) and Contract Commercial Organization (CCO) to transform a fragmented company into a unified, global entity.
inVentiv Health relaunched as Syneos Health™ in 2018 (Nasdaq:SYNH) as the only fully integrated biopharmaceutical solutions organization with more than 23,000 clinical and commercial minds and the ability to support customers in more than 110 countries, together conducting business worth
$4.3 Billion.
With new collaborations, opportunities to develop convergent solutions for healthcare clients became the norm and the company began to operate with singularity in its purpose. After three years of space-making, we had finally established an organized and integrated operations which brought together a Contract Research Organization (CRO) and Contract Commercial Organization (CCO) to transform a fragmented company into a unified, global entity.
inVentiv Health relaunched as Syneos Health™ in 2018 (Nasdaq:SYNH) as the only fully integrated biopharmaceutical solutions organization with more than 23,000 clinical and commercial minds and the ability to support customers in more than 110 countries, together conducting business worth
$4.3 Billion.
